NDC Package 0173-0857-02 Diluent

Water Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0173-0857-02
Package Description:
2 VIAL in 1 TRAY / 50 mL in 1 VIAL
Product Code:
Proprietary Name:
Diluent
Non-Proprietary Name:
Water
Substance Name:
Water
Usage Information:
FLOLAN® is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise capacity. Trials establishing effectiveness included predominantly (97%) patients with New York Heart Association (NYHA) Functional Class III-IV symptoms and etiologies of idiopathic or heritable PAH (49%) or PAH associated with connective tissue diseases (51%).
11-Digit NDC Billing Format:
00173085702
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 211199 - FLOLAN 0.5 MG Injection
  • RxCUI: 211199 - epoprostenol 0.5 MG Injection [Flolan]
  • RxCUI: 211199 - Flolan 0.5 MG (as epoprostenol sodium) Injection
  • RxCUI: 211200 - FLOLAN 1.5 MG Injection
  • RxCUI: 211200 - epoprostenol 1.5 MG Injection [Flolan]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Glaxosmithkline Llc
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA020444
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    04-01-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0173-0857-02?

    The NDC Packaged Code 0173-0857-02 is assigned to a package of 2 vial in 1 tray / 50 ml in 1 vial of Diluent, a human prescription drug labeled by Glaxosmithkline Llc. The product's dosage form is solution and is administered via intravenous form.

    Is NDC 0173-0857 included in the NDC Directory?

    Yes, Diluent with product code 0173-0857 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on April 01, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0173-0857-02?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0173-0857-02?

    The 11-digit format is 00173085702. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20173-0857-025-4-200173-0857-02